Maxim’s healthcare analyst Jason McCarthy weighed in with some commentary on Juno Therapeutics Inc (NASDAQ:JUNO), after the company announced that FDA has cleared its investigational new drug application for …
Juno Therapeutics Inc (NASDAQ:JUNO), a biopharmaceutical company focused on re-engaging the body’s immune system to revolutionize the treatment of cancer, today announced the U.S.
Shares of Juno Therapeutics Inc (NASDAQ:JUNO) closed yesterday up 15% following the announcement of the company’s collaboration with Celgene Corporation. In response, J.
On June 29, Juno Therapeutics Inc (NASDAQ:JUNO) and Celgene Corporation (NASDAQ:CELG) announced a ten-year collaboration to develop new therapies for cancer and auto-immune …
The modern pharmaceutical industry as we know it is one of the newest industries in the world. This is because the tools that …
Wall Street analysts are weighing today on Celgene Corporation (NASDAQ:CELG) after the pharmaceutical giant announced a 10-year broad collaboration with Juno Therapeutics Inc (NASDAQ:JUNO) to advance T-cell …
Global X Funds (NYSEARCA:GREK) shares are up 3.4% in pre-market trading to $9.
Celgene Corporation (NASDAQ:CELG) has placed its bet in the race to develop and market T cell therapies for oncology with a $1 billion …
Recently, various executives have taken part in insider selling activity for the stocks of Walt Disney Co (NYSE:DIS), Oracle Corporation (NYSE:ORCL), Juno Therapeutics Inc (NASDAQ:JUNO), and Veeva Systems …
Oracle Corporation (NYSE:ORCL) fell -6.3% in pre-market trading to $42.
